|
GATAD2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.512000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.975200E-01 |
| Normal-vs-Stage2 |
3.935400E-01 |
| Normal-vs-Stage3 |
6.073800E-02 |
| Normal-vs-Stage4 |
6.323400E-01 |
| Stage1-vs-Stage2 |
5.661600E-01 |
| Stage1-vs-Stage3 |
1.364180E-01 |
| Stage1-vs-Stage4 |
3.693200E-01 |
| Stage2-vs-Stage3 |
6.060400E-01 |
| Stage2-vs-Stage4 |
3.697000E-01 |
| Stage3-vs-Stage4 |
1.163600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.664800E-01 |
| Normal-vs-AfricanAmerican |
1.426370E-01 |
| Normal-vs-Asian |
5.549200E-01 |
| Caucasian-vs-AfricanAmerican |
2.321200E-01 |
| Caucasian-vs-Asian |
4.042400E-01 |
| AfricanAmerican-vs-Asian |
2.360600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.819800E-01 |
| Normal-vs-Female |
8.457600E-02 |
| Male-vs-Female |
1.439790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.591400E-01 |
| Normal-vs-Extreme_Weight |
5.282800E-01 |
| Normal-vs-Obese |
5.273900E-02 |
| Normal-vs-Extreme_Obese |
3.164400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.565000E-01 |
| Normal_Weight-vs-Obese |
8.143900E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.482600E-01 |
| Extreme_Weight-vs-Obese |
1.039050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.811200E-01 |
| Obese-vs-Extreme_Obese |
7.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.756100E-03 |
| Normal-vs-Age(41-60Yrs) |
9.774000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.246800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.804000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.389040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.424500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.244380E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.364400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.908500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.806800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.009410E-01 |
| Normal-VS-Type2 PRCC |
8.599800E-01 |
| Normal-VS-KIRP CIMP |
7.943800E-02 |
| Normal-VS-Unclassified PRCC |
2.807000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.707660E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.162200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.634400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.835900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.873160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.108600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.522400E-01 |
| Normal-vs-N1 |
9.657900E-02 |
| Normal-vs-N2 |
9.657600E-01 |
| N0-vs-N1 |
1.275220E-01 |
| N0-vs-N2 |
9.691400E-01 |
| N1-vs-N2 |
4.939000E-01 |
|
|
